This Penny Stock Is Pivoting to the Zcash Crypto. Should You Buy Shares After Its November 13 Rebrand?

Core Insights - Leap Therapeutics (LPTX) shares surged by 368% on November 12 following the announcement of a crypto treasury strategy focused on ZCash (ZECUSD) [1] - The company secured nearly $59 million in private placement funding, with $50 million immediately allocated to acquire 203,775 ZEC tokens [1] - Leap Therapeutics will officially rebrand as Cypherpunk Technologies on November 13 and will trade under the new ticker symbol CYPH [2] Company Strategy - The announcement positions Leap Therapeutics as a digital asset treasury company, aiming to capitalize on the momentum of ZCash, which has increased over 1,400% in 2025 [3] - ZCash is recognized among crypto enthusiasts as "encrypted Bitcoin," and its price is expected to rise due to its safety features in a digital economy [3] - The ZCash treasury strategy is anticipated to attract crypto-focused investors, potentially driving share prices higher in 2026 [4] Market Context - The transformation into a digital asset treasury company aligns with the growing interest in cryptocurrencies, particularly privacy-focused assets like ZCash [3][4] - The increasing demand for ZCash may enhance its market position, especially as it is viewed as a scarce commodity [3] Regulatory Environment - Privacy-focused cryptocurrencies, including ZCash, face significant regulatory challenges, such as the European Union's planned 2027 ban on privacy coins [5] - Major exchanges have begun delisting privacy assets to comply with regulations, which could impact the liquidity and distribution of ZCash [6]